🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Risk of Recurrent CeAD After Pregnancy

Recruitingn/aAges 18 Years - anyFemaleUniversity Hospital, Basel, Switzerland
NCT06258109 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Primary objective: To determine whether pregnancy increases the risk of recurrent CeAD and delayed stroke in women with prior CeAD based on long-term data. Methods: Multicentric, observational case-control study based on pooled individual patient data from several stroke centers. Primary endpoint: Primary composite outcome measure includes the following outcomes: (i) occurrence of recurrent CeAD, (ii) occurrence of ischemic or hemorrhagic stroke, (iii) death.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * female * prior symptomatic cervical artery dissection (= index CeAD) * at least one long-term follow-up visit (at least 6 months after the initial event) * with information available on outcome events: * recurrent dissection * ischemic stroke * hemorrhagic stroke * functional outcome assessed by mRS score * with data on pregnancy after the initial event * at least 18 years old at the initial event Exclusion Criteria: * Male patients * Age \<18 years * No long-term follow-up available or long-term follow-up \< 6 months after initial event * No data on pregnancy after initial event available
💊

What it tests

  • Not listed
📍

Where

12 sites
University of Utah
Salt Lake City, United States
University of Virginia
Charlottesville, United States
Stroke Unit Sanatorio Allende
Córdoba, Argentina
Department of Neurology, Medical University of Innsbruck
Innsbruck, Austria
Helsinki University Central Hospital
Helsinki, Finland
Charité Universitätsmedizin, Centrum für Schlaganfallforschung
Berlin, Germany
Neurologische Klinik und Poliklinik, LMU Klinikum Campus Großhadern
Munich, Germany
Hadassah-Hebrew University Medical Center
Jerusalem, Israel

…and 4 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy